Clinical Trial Update: GSK2339345 Hypertussive Challenge Study [Phase 2]

View source ↗

Summary

GlaxoSmithKline's Phase 2 Hypertussive Challenge Study of GSK2339345 for cough has completed and results were posted in April 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• GSK2339345

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cough | Phase 2 | Status: COMPLETED | Results posted: 2017-04-05